Biperiden

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Biperiden, sold under the brand name Akineton among others, is a medication used to treat Parkinson disease, certain drug-induced movement disorders and Tourette Syndrome . It is not recommended for tardive dyskinesias. It is taken by mouth, injection into a vein, or muscle.

Common side effects include blurred vision, dry mouth, sleepiness, constipation, and confusion. It should not be used in people with a bowel obstruction or glaucoma. It is unclear if use in pregnancy or breastfeeding is safe.

Biperiden is in the anticholinergic family of medication. Biperiden was approved for medical use in the United States in 1959. It is on the World Health Organization's List of Essential Medicines.

Biperiden is no longer marketed in the United States.

Biperiden, sold under the brand name Akineton among others, is a medication used to treat Parkinson disease, certain drug-induced movement disorders and Tourette Syndrome . It is not recommended for tardive dyskinesias. It is taken by mouth, injection into a vein, or muscle.

Common side effects include blurred vision, dry mouth, sleepiness, constipation, and confusion. It should not be used in people with a bowel obstruction or glaucoma. It is unclear if use in pregnancy or breastfeeding is safe.

Biperiden is in the anticholinergic family of medication. Biperiden was approved for medical use in the United States in 1959. It is on the World Health Organization's List of Essential Medicines.

Biperiden is no longer marketed in the United States.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1338211165 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

12 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.